nodes	percent_of_prediction	percent_of_DWPC	metapath
Dexamethasone—hematologic cancer—muscle cancer	0.435	1	CtDrD
Dexamethasone—PTGS2—muscle cancer	0.128	1	CbGaD
Dexamethasone—NR0B1—Vincristine—muscle cancer	0.0927	0.26	CbGbCtD
Dexamethasone—NOS2—Doxorubicin—muscle cancer	0.0485	0.136	CbGbCtD
Dexamethasone—ABCB11—Vincristine—muscle cancer	0.0185	0.0519	CbGbCtD
Dexamethasone—CYP1A1—Dacarbazine—muscle cancer	0.0152	0.0427	CbGbCtD
Dexamethasone—ABCG2—Dactinomycin—muscle cancer	0.0143	0.0401	CbGbCtD
Dexamethasone—CYP2E1—Dacarbazine—muscle cancer	0.0117	0.033	CbGbCtD
Dexamethasone—CYP1B1—Doxorubicin—muscle cancer	0.0116	0.0324	CbGbCtD
Dexamethasone—ABCB11—Doxorubicin—muscle cancer	0.0116	0.0324	CbGbCtD
Dexamethasone—ABCC2—Vincristine—muscle cancer	0.00972	0.0273	CbGbCtD
Dexamethasone—ABCC2—Etoposide—muscle cancer	0.00891	0.025	CbGbCtD
Dexamethasone—PTGS2—Etoposide—muscle cancer	0.00881	0.0247	CbGbCtD
Dexamethasone—ABCG2—Vincristine—muscle cancer	0.00879	0.0247	CbGbCtD
Dexamethasone—ABCG2—Etoposide—muscle cancer	0.00806	0.0226	CbGbCtD
Dexamethasone—SLCO1A2—Methotrexate—muscle cancer	0.0071	0.0199	CbGbCtD
Dexamethasone—CYP3A7—Vincristine—muscle cancer	0.00649	0.0182	CbGbCtD
Dexamethasone—CYP3A7-CYP3A51P—Vincristine—muscle cancer	0.00649	0.0182	CbGbCtD
Dexamethasone—ABCC2—Doxorubicin—muscle cancer	0.00608	0.0171	CbGbCtD
Dexamethasone—ABCC2—Methotrexate—muscle cancer	0.00589	0.0165	CbGbCtD
Dexamethasone—CYP2E1—Etoposide—muscle cancer	0.00574	0.0161	CbGbCtD
Dexamethasone—ABCG2—Doxorubicin—muscle cancer	0.00549	0.0154	CbGbCtD
Dexamethasone—ABCG2—Methotrexate—muscle cancer	0.00532	0.0149	CbGbCtD
Dexamethasone—ABCB1—Dactinomycin—muscle cancer	0.00515	0.0144	CbGbCtD
Dexamethasone—CYP3A5—Vincristine—muscle cancer	0.00487	0.0137	CbGbCtD
Dexamethasone—CYP3A5—Etoposide—muscle cancer	0.00446	0.0125	CbGbCtD
Dexamethasone—CYP2C8—Etoposide—muscle cancer	0.00429	0.012	CbGbCtD
Dexamethasone—CYP2B6—Doxorubicin—muscle cancer	0.00386	0.0108	CbGbCtD
Dexamethasone—ABCB1—Vincristine—muscle cancer	0.00317	0.0089	CbGbCtD
Dexamethasone—ABCB1—Etoposide—muscle cancer	0.0029	0.00815	CbGbCtD
Dexamethasone—ABCB1—Doxorubicin—muscle cancer	0.00198	0.00556	CbGbCtD
Dexamethasone—ABCB1—Methotrexate—muscle cancer	0.00192	0.00539	CbGbCtD
Dexamethasone—CYP3A4—Vincristine—muscle cancer	0.0019	0.00533	CbGbCtD
Dexamethasone—CYP2D6—Doxorubicin—muscle cancer	0.00187	0.00524	CbGbCtD
Dexamethasone—CYP3A4—Etoposide—muscle cancer	0.00174	0.00489	CbGbCtD
Dexamethasone—NOS2—tendon—muscle cancer	0.0012	0.0547	CbGeAlD
Dexamethasone—CYP3A4—Doxorubicin—muscle cancer	0.00119	0.00333	CbGbCtD
Dexamethasone—CYP4A11—renal system—muscle cancer	0.000708	0.0322	CbGeAlD
Dexamethasone—CYP3A43—testis—muscle cancer	0.000642	0.0292	CbGeAlD
Dexamethasone—PTGS2—hindlimb—muscle cancer	0.000625	0.0284	CbGeAlD
Dexamethasone—ANXA1—embryo—muscle cancer	0.000592	0.0269	CbGeAlD
Dexamethasone—PLA2G1B—renal system—muscle cancer	0.000586	0.0267	CbGeAlD
Dexamethasone—PTGS2—appendage—muscle cancer	0.000536	0.0244	CbGeAlD
Dexamethasone—NR0B1—testis—muscle cancer	0.000532	0.0242	CbGeAlD
Dexamethasone—CYP4A11—vagina—muscle cancer	0.000512	0.0233	CbGeAlD
Dexamethasone—ANXA1—smooth muscle tissue—muscle cancer	0.000466	0.0212	CbGeAlD
Dexamethasone—ANXA1—renal system—muscle cancer	0.000448	0.0204	CbGeAlD
Dexamethasone—CYP17A1—renal system—muscle cancer	0.000402	0.0183	CbGeAlD
Dexamethasone—ANXA1—cardiac atrium—muscle cancer	0.000402	0.0183	CbGeAlD
Dexamethasone—PLA2G1B—head—muscle cancer	0.000392	0.0178	CbGeAlD
Dexamethasone—PLA2G1B—testis—muscle cancer	0.000379	0.0172	CbGeAlD
Dexamethasone—ANXA1—tendon—muscle cancer	0.00035	0.0159	CbGeAlD
Dexamethasone—ANXA1—bone marrow—muscle cancer	0.000339	0.0154	CbGeAlD
Dexamethasone—ANXA1—vagina—muscle cancer	0.000325	0.0148	CbGeAlD
Dexamethasone—NR3C2—smooth muscle tissue—muscle cancer	0.000302	0.0137	CbGeAlD
Dexamethasone—ANXA1—head—muscle cancer	0.0003	0.0136	CbGeAlD
Dexamethasone—ABCB11—testis—muscle cancer	0.000295	0.0134	CbGeAlD
Dexamethasone—NR3C2—renal system—muscle cancer	0.00029	0.0132	CbGeAlD
Dexamethasone—ANXA1—testis—muscle cancer	0.00029	0.0132	CbGeAlD
Dexamethasone—PGR—smooth muscle tissue—muscle cancer	0.00028	0.0127	CbGeAlD
Dexamethasone—CYP17A1—head—muscle cancer	0.000269	0.0122	CbGeAlD
Dexamethasone—NR3C2—cardiac atrium—muscle cancer	0.00026	0.0118	CbGeAlD
Dexamethasone—CYP17A1—testis—muscle cancer	0.00026	0.0118	CbGeAlD
Dexamethasone—CYP11A1—head—muscle cancer	0.00025	0.0114	CbGeAlD
Dexamethasone—SLCO1A2—renal system—muscle cancer	0.000249	0.0113	CbGeAlD
Dexamethasone—CYP11A1—testis—muscle cancer	0.000242	0.011	CbGeAlD
Dexamethasone—CYP1B1—smooth muscle tissue—muscle cancer	0.000236	0.0107	CbGeAlD
Dexamethasone—ABCC2—renal system—muscle cancer	0.000232	0.0105	CbGeAlD
Dexamethasone—CYP1B1—renal system—muscle cancer	0.000227	0.0103	CbGeAlD
Dexamethasone—NR3C2—tendon—muscle cancer	0.000227	0.0103	CbGeAlD
Dexamethasone—CYP2A6—vagina—muscle cancer	0.000224	0.0102	CbGeAlD
Dexamethasone—NR3C2—vagina—muscle cancer	0.00021	0.00956	CbGeAlD
Dexamethasone—NR3C1—embryo—muscle cancer	0.000206	0.00936	CbGeAlD
Dexamethasone—PGR—vagina—muscle cancer	0.000195	0.00889	CbGeAlD
Dexamethasone—NR3C2—head—muscle cancer	0.000194	0.00883	CbGeAlD
Dexamethasone—NR3C2—testis—muscle cancer	0.000188	0.00853	CbGeAlD
Dexamethasone—ABCC2—tendon—muscle cancer	0.000181	0.00823	CbGeAlD
Dexamethasone—PGR—head—muscle cancer	0.000181	0.00821	CbGeAlD
Dexamethasone—PTGS2—embryo—muscle cancer	0.000178	0.0081	CbGeAlD
Dexamethasone—CYP1B1—tendon—muscle cancer	0.000177	0.00806	CbGeAlD
Dexamethasone—PGR—testis—muscle cancer	0.000174	0.00793	CbGeAlD
Dexamethasone—CYP2C8—renal system—muscle cancer	0.000174	0.00791	CbGeAlD
Dexamethasone—SLCO1A2—head—muscle cancer	0.000167	0.00757	CbGeAlD
Dexamethasone—CYP19A1—head—muscle cancer	0.000162	0.00739	CbGeAlD
Dexamethasone—NR3C1—smooth muscle tissue—muscle cancer	0.000162	0.00736	CbGeAlD
Dexamethasone—SLCO1A2—testis—muscle cancer	0.000161	0.00731	CbGeAlD
Dexamethasone—CYP1A1—renal system—muscle cancer	0.00016	0.0073	CbGeAlD
Dexamethasone—CYP19A1—testis—muscle cancer	0.000157	0.00714	CbGeAlD
Dexamethasone—CYP3A5—renal system—muscle cancer	0.000157	0.00714	CbGeAlD
Dexamethasone—CYP2B6—renal system—muscle cancer	0.000156	0.00709	CbGeAlD
Dexamethasone—NR3C1—renal system—muscle cancer	0.000156	0.00708	CbGeAlD
Dexamethasone—Acute coronary syndrome—Vincristine—muscle cancer	0.000152	0.00339	CcSEcCtD
Dexamethasone—CYP1B1—head—muscle cancer	0.000152	0.00691	CbGeAlD
Dexamethasone—Rash erythematous—Doxorubicin—muscle cancer	0.000151	0.00337	CcSEcCtD
Dexamethasone—Myocardial infarction—Vincristine—muscle cancer	0.000151	0.00337	CcSEcCtD
Dexamethasone—Neuropathy peripheral—Vincristine—muscle cancer	0.000151	0.00337	CcSEcCtD
Dexamethasone—Fungal infection—Doxorubicin—muscle cancer	0.00015	0.00334	CcSEcCtD
Dexamethasone—ABCC2—testis—muscle cancer	0.00015	0.00681	CbGeAlD
Dexamethasone—Necrosis—Doxorubicin—muscle cancer	0.000148	0.00329	CcSEcCtD
Dexamethasone—CYP1B1—testis—muscle cancer	0.000147	0.00667	CbGeAlD
Dexamethasone—Abscess—Doxorubicin—muscle cancer	0.000147	0.00326	CcSEcCtD
Dexamethasone—CYP2E1—renal system—muscle cancer	0.000146	0.00666	CbGeAlD
Dexamethasone—Herpes simplex—Methotrexate—muscle cancer	0.000145	0.00323	CcSEcCtD
Dexamethasone—CYP2C19—vagina—muscle cancer	0.000144	0.00656	CbGeAlD
Dexamethasone—CYP1A1—cardiac atrium—muscle cancer	0.000144	0.00654	CbGeAlD
Dexamethasone—Stinging—Doxorubicin—muscle cancer	0.000143	0.00318	CcSEcCtD
Dexamethasone—Glycosuria—Doxorubicin—muscle cancer	0.000143	0.00318	CcSEcCtD
Dexamethasone—Ulcer—Methotrexate—muscle cancer	0.000142	0.00315	CcSEcCtD
Dexamethasone—Petechiae—Doxorubicin—muscle cancer	0.000141	0.00314	CcSEcCtD
Dexamethasone—PTGS2—smooth muscle tissue—muscle cancer	0.00014	0.00637	CbGeAlD
Dexamethasone—NR3C1—cardiac atrium—muscle cancer	0.000139	0.00634	CbGeAlD
Dexamethasone—Hallucination—Vincristine—muscle cancer	0.000138	0.00307	CcSEcCtD
Dexamethasone—Vasculitis—Methotrexate—muscle cancer	0.000137	0.00305	CcSEcCtD
Dexamethasone—Alopecia—Dactinomycin—muscle cancer	0.000137	0.00305	CcSEcCtD
Dexamethasone—Sweating increased—Etoposide—muscle cancer	0.000137	0.00304	CcSEcCtD
Dexamethasone—Erythema—Dactinomycin—muscle cancer	0.000135	0.003	CcSEcCtD
Dexamethasone—PTGS2—renal system—muscle cancer	0.000135	0.00613	CbGeAlD
Dexamethasone—Extravasation—Doxorubicin—muscle cancer	0.000133	0.00296	CcSEcCtD
Dexamethasone—Amenorrhoea—Doxorubicin—muscle cancer	0.000132	0.00294	CcSEcCtD
Dexamethasone—Skin exfoliation—Methotrexate—muscle cancer	0.000128	0.00284	CcSEcCtD
Dexamethasone—ABCG2—bone marrow—muscle cancer	0.000128	0.00581	CbGeAlD
Dexamethasone—Arthropathy—Doxorubicin—muscle cancer	0.000128	0.00284	CcSEcCtD
Dexamethasone—CYP2C8—vagina—muscle cancer	0.000126	0.00573	CbGeAlD
Dexamethasone—Herpes simplex—Doxorubicin—muscle cancer	0.000126	0.0028	CcSEcCtD
Dexamethasone—Angiopathy—Vincristine—muscle cancer	0.000126	0.0028	CcSEcCtD
Dexamethasone—Ill-defined disorder—Dactinomycin—muscle cancer	0.000125	0.00279	CcSEcCtD
Dexamethasone—Acute coronary syndrome—Etoposide—muscle cancer	0.000123	0.00274	CcSEcCtD
Dexamethasone—Ulcer—Doxorubicin—muscle cancer	0.000123	0.00273	CcSEcCtD
Dexamethasone—Neuropathy peripheral—Etoposide—muscle cancer	0.000123	0.00273	CcSEcCtD
Dexamethasone—Myocardial infarction—Etoposide—muscle cancer	0.000123	0.00273	CcSEcCtD
Dexamethasone—Alopecia—Vincristine—muscle cancer	0.000122	0.00272	CcSEcCtD
Dexamethasone—ABCG2—vagina—muscle cancer	0.000122	0.00557	CbGeAlD
Dexamethasone—Malaise—Dactinomycin—muscle cancer	0.000122	0.00271	CcSEcCtD
Dexamethasone—NR3C1—tendon—muscle cancer	0.000122	0.00553	CbGeAlD
Dexamethasone—Ecchymosis—Methotrexate—muscle cancer	0.000121	0.00269	CcSEcCtD
Dexamethasone—Pulmonary oedema—Methotrexate—muscle cancer	0.000119	0.00265	CcSEcCtD
Dexamethasone—CYP3A4—renal system—muscle cancer	0.000118	0.00536	CbGeAlD
Dexamethasone—NR3C1—bone marrow—muscle cancer	0.000118	0.00535	CbGeAlD
Dexamethasone—CYP1A1—vagina—muscle cancer	0.000116	0.00529	CbGeAlD
Dexamethasone—Hiccups—Doxorubicin—muscle cancer	0.000116	0.00258	CcSEcCtD
Dexamethasone—CYP2D6—renal system—muscle cancer	0.000116	0.00527	CbGeAlD
Dexamethasone—Myalgia—Dactinomycin—muscle cancer	0.000115	0.00256	CcSEcCtD
Dexamethasone—Dermatitis contact—Doxorubicin—muscle cancer	0.000115	0.00255	CcSEcCtD
Dexamethasone—CYP2E1—tendon—muscle cancer	0.000114	0.0052	CbGeAlD
Dexamethasone—CYP3A5—vagina—muscle cancer	0.000114	0.00517	CbGeAlD
Dexamethasone—Discomfort—Dactinomycin—muscle cancer	0.000114	0.00253	CcSEcCtD
Dexamethasone—CYP2B6—vagina—muscle cancer	0.000113	0.00514	CbGeAlD
Dexamethasone—NR3C1—vagina—muscle cancer	0.000113	0.00513	CbGeAlD
Dexamethasone—CYP2C8—testis—muscle cancer	0.000112	0.00511	CbGeAlD
Dexamethasone—Thrombophlebitis—Methotrexate—muscle cancer	0.000112	0.0025	CcSEcCtD
Dexamethasone—Diabetes mellitus—Methotrexate—muscle cancer	0.000112	0.00249	CcSEcCtD
Dexamethasone—Skin exfoliation—Doxorubicin—muscle cancer	0.000111	0.00246	CcSEcCtD
Dexamethasone—Oedema—Dactinomycin—muscle cancer	0.00011	0.00245	CcSEcCtD
Dexamethasone—ABCB1—embryo—muscle cancer	0.00011	0.00501	CbGeAlD
Dexamethasone—Fluid retention—Doxorubicin—muscle cancer	0.00011	0.00245	CcSEcCtD
Dexamethasone—Infection—Dactinomycin—muscle cancer	0.00011	0.00244	CcSEcCtD
Dexamethasone—ABCG2—testis—muscle cancer	0.000109	0.00497	CbGeAlD
Dexamethasone—Neuropathy—Doxorubicin—muscle cancer	0.000109	0.00242	CcSEcCtD
Dexamethasone—Vertigo—Vincristine—muscle cancer	0.000108	0.00241	CcSEcCtD
Dexamethasone—Thrombocytopenia—Dactinomycin—muscle cancer	0.000108	0.0024	CcSEcCtD
Dexamethasone—CYP1A1—head—muscle cancer	0.000107	0.00488	CbGeAlD
Dexamethasone—Dry eye—Doxorubicin—muscle cancer	0.000107	0.00238	CcSEcCtD
Dexamethasone—Oesophagitis—Doxorubicin—muscle cancer	0.000106	0.00236	CcSEcCtD
Dexamethasone—PTGS2—tendon—muscle cancer	0.000105	0.00478	CbGeAlD
Dexamethasone—Anorexia—Dactinomycin—muscle cancer	0.000105	0.00234	CcSEcCtD
Dexamethasone—Eye disorder—Etoposide—muscle cancer	0.000105	0.00233	CcSEcCtD
Dexamethasone—Ecchymosis—Doxorubicin—muscle cancer	0.000105	0.00233	CcSEcCtD
Dexamethasone—Convulsion—Vincristine—muscle cancer	0.000105	0.00233	CcSEcCtD
Dexamethasone—CYP2B6—head—muscle cancer	0.000104	0.00475	CbGeAlD
Dexamethasone—NR3C1—head—muscle cancer	0.000104	0.00474	CbGeAlD
Dexamethasone—Hypertension—Vincristine—muscle cancer	0.000104	0.00232	CcSEcCtD
Dexamethasone—Pulmonary oedema—Doxorubicin—muscle cancer	0.000103	0.0023	CcSEcCtD
Dexamethasone—Myalgia—Vincristine—muscle cancer	0.000103	0.00229	CcSEcCtD
Dexamethasone—Visual disturbance—Methotrexate—muscle cancer	0.000103	0.00228	CcSEcCtD
Dexamethasone—PTGS2—bone marrow—muscle cancer	0.000102	0.00463	CbGeAlD
Dexamethasone—Angiopathy—Etoposide—muscle cancer	0.000102	0.00227	CcSEcCtD
Dexamethasone—CYP2B6—testis—muscle cancer	0.000101	0.00458	CbGeAlD
Dexamethasone—NR3C1—testis—muscle cancer	0.000101	0.00458	CbGeAlD
Dexamethasone—Anaphylactoid reaction—Methotrexate—muscle cancer	0.0001	0.00223	CcSEcCtD
Dexamethasone—Musculoskeletal discomfort—Dactinomycin—muscle cancer	0.0001	0.00223	CcSEcCtD
Dexamethasone—Alopecia—Etoposide—muscle cancer	9.92e-05	0.00221	CcSEcCtD
Dexamethasone—Lethargy—Methotrexate—muscle cancer	9.92e-05	0.00221	CcSEcCtD
Dexamethasone—Anaphylactic shock—Vincristine—muscle cancer	9.85e-05	0.00219	CcSEcCtD
Dexamethasone—Oedema—Vincristine—muscle cancer	9.85e-05	0.00219	CcSEcCtD
Dexamethasone—CYP2E1—head—muscle cancer	9.79e-05	0.00445	CbGeAlD
Dexamethasone—Infection—Vincristine—muscle cancer	9.78e-05	0.00218	CcSEcCtD
Dexamethasone—PTGS2—vagina—muscle cancer	9.76e-05	0.00444	CbGeAlD
Dexamethasone—Thrombophlebitis—Doxorubicin—muscle cancer	9.73e-05	0.00216	CcSEcCtD
Dexamethasone—Osteoarthritis—Methotrexate—muscle cancer	9.72e-05	0.00216	CcSEcCtD
Dexamethasone—Diabetes mellitus—Doxorubicin—muscle cancer	9.68e-05	0.00215	CcSEcCtD
Dexamethasone—Nervous system disorder—Vincristine—muscle cancer	9.66e-05	0.00215	CcSEcCtD
Dexamethasone—Thrombocytopenia—Vincristine—muscle cancer	9.64e-05	0.00215	CcSEcCtD
Dexamethasone—Decreased appetite—Dactinomycin—muscle cancer	9.58e-05	0.00213	CcSEcCtD
Dexamethasone—Hyperhidrosis—Vincristine—muscle cancer	9.52e-05	0.00212	CcSEcCtD
Dexamethasone—Fatigue—Dactinomycin—muscle cancer	9.5e-05	0.00211	CcSEcCtD
Dexamethasone—CYP2E1—testis—muscle cancer	9.46e-05	0.0043	CbGeAlD
Dexamethasone—Pain—Dactinomycin—muscle cancer	9.43e-05	0.0021	CcSEcCtD
Dexamethasone—Anorexia—Vincristine—muscle cancer	9.39e-05	0.00209	CcSEcCtD
Dexamethasone—Eye pain—Doxorubicin—muscle cancer	9.33e-05	0.00207	CcSEcCtD
Dexamethasone—Cardiac failure congestive—Doxorubicin—muscle cancer	9.28e-05	0.00207	CcSEcCtD
Dexamethasone—Irritability—Methotrexate—muscle cancer	9.28e-05	0.00206	CcSEcCtD
Dexamethasone—Mood swings—Methotrexate—muscle cancer	9.21e-05	0.00205	CcSEcCtD
Dexamethasone—Hypotension—Vincristine—muscle cancer	9.2e-05	0.00205	CcSEcCtD
Dexamethasone—Feeling abnormal—Dactinomycin—muscle cancer	9.08e-05	0.00202	CcSEcCtD
Dexamethasone—Ill-defined disorder—Etoposide—muscle cancer	9.07e-05	0.00202	CcSEcCtD
Dexamethasone—PTGS2—head—muscle cancer	9.02e-05	0.0041	CbGeAlD
Dexamethasone—Gastrointestinal pain—Dactinomycin—muscle cancer	9.01e-05	0.00201	CcSEcCtD
Dexamethasone—Musculoskeletal discomfort—Vincristine—muscle cancer	8.97e-05	0.002	CcSEcCtD
Dexamethasone—Increased appetite—Doxorubicin—muscle cancer	8.96e-05	0.00199	CcSEcCtD
Dexamethasone—Insomnia—Vincristine—muscle cancer	8.91e-05	0.00198	CcSEcCtD
Dexamethasone—Paraesthesia—Vincristine—muscle cancer	8.84e-05	0.00197	CcSEcCtD
Dexamethasone—Malaise—Etoposide—muscle cancer	8.82e-05	0.00196	CcSEcCtD
Dexamethasone—Dermatitis bullous—Doxorubicin—muscle cancer	8.81e-05	0.00196	CcSEcCtD
Dexamethasone—Vertigo—Etoposide—muscle cancer	8.78e-05	0.00195	CcSEcCtD
Dexamethasone—Abdominal pain—Dactinomycin—muscle cancer	8.71e-05	0.00194	CcSEcCtD
Dexamethasone—Body temperature increased—Dactinomycin—muscle cancer	8.71e-05	0.00194	CcSEcCtD
Dexamethasone—Anaphylactoid reaction—Doxorubicin—muscle cancer	8.7e-05	0.00193	CcSEcCtD
Dexamethasone—Cardiac failure—Doxorubicin—muscle cancer	8.63e-05	0.00192	CcSEcCtD
Dexamethasone—Loss of consciousness—Etoposide—muscle cancer	8.59e-05	0.00191	CcSEcCtD
Dexamethasone—Lethargy—Doxorubicin—muscle cancer	8.59e-05	0.00191	CcSEcCtD
Dexamethasone—Decreased appetite—Vincristine—muscle cancer	8.56e-05	0.0019	CcSEcCtD
Dexamethasone—Gastrointestinal disorder—Vincristine—muscle cancer	8.5e-05	0.00189	CcSEcCtD
Dexamethasone—Fatigue—Vincristine—muscle cancer	8.49e-05	0.00189	CcSEcCtD
Dexamethasone—Convulsion—Etoposide—muscle cancer	8.47e-05	0.00188	CcSEcCtD
Dexamethasone—Hypertension—Etoposide—muscle cancer	8.44e-05	0.00188	CcSEcCtD
Dexamethasone—Pain—Vincristine—muscle cancer	8.42e-05	0.00187	CcSEcCtD
Dexamethasone—Osteoarthritis—Doxorubicin—muscle cancer	8.42e-05	0.00187	CcSEcCtD
Dexamethasone—ABCB1—renal system—muscle cancer	8.34e-05	0.00379	CbGeAlD
Dexamethasone—Migraine—Doxorubicin—muscle cancer	8.29e-05	0.00184	CcSEcCtD
Dexamethasone—Affect lability—Doxorubicin—muscle cancer	8.29e-05	0.00184	CcSEcCtD
Dexamethasone—Discomfort—Etoposide—muscle cancer	8.22e-05	0.00183	CcSEcCtD
Dexamethasone—Gastrointestinal pain—Vincristine—muscle cancer	8.05e-05	0.00179	CcSEcCtD
Dexamethasone—Cardiac arrest—Doxorubicin—muscle cancer	8.01e-05	0.00178	CcSEcCtD
Dexamethasone—Anaphylactic shock—Etoposide—muscle cancer	7.98e-05	0.00177	CcSEcCtD
Dexamethasone—Mood swings—Doxorubicin—muscle cancer	7.98e-05	0.00177	CcSEcCtD
Dexamethasone—Infection—Etoposide—muscle cancer	7.93e-05	0.00176	CcSEcCtD
Dexamethasone—Asthenia—Dactinomycin—muscle cancer	7.91e-05	0.00176	CcSEcCtD
Dexamethasone—Thrombocytopenia—Etoposide—muscle cancer	7.81e-05	0.00174	CcSEcCtD
Dexamethasone—Tachycardia—Etoposide—muscle cancer	7.79e-05	0.00173	CcSEcCtD
Dexamethasone—Body temperature increased—Vincristine—muscle cancer	7.79e-05	0.00173	CcSEcCtD
Dexamethasone—Abdominal pain—Vincristine—muscle cancer	7.79e-05	0.00173	CcSEcCtD
Dexamethasone—CYP2D6—head—muscle cancer	7.75e-05	0.00353	CbGeAlD
Dexamethasone—Dry skin—Doxorubicin—muscle cancer	7.72e-05	0.00172	CcSEcCtD
Dexamethasone—Hyperhidrosis—Etoposide—muscle cancer	7.71e-05	0.00172	CcSEcCtD
Dexamethasone—Hypokalaemia—Doxorubicin—muscle cancer	7.66e-05	0.0017	CcSEcCtD
Dexamethasone—Anorexia—Etoposide—muscle cancer	7.6e-05	0.00169	CcSEcCtD
Dexamethasone—Diarrhoea—Dactinomycin—muscle cancer	7.54e-05	0.00168	CcSEcCtD
Dexamethasone—CYP2D6—testis—muscle cancer	7.49e-05	0.00341	CbGeAlD
Dexamethasone—Hypotension—Etoposide—muscle cancer	7.45e-05	0.00166	CcSEcCtD
Dexamethasone—Muscular weakness—Doxorubicin—muscle cancer	7.43e-05	0.00165	CcSEcCtD
Dexamethasone—Conjunctivitis—Methotrexate—muscle cancer	7.28e-05	0.00162	CcSEcCtD
Dexamethasone—Paraesthesia—Etoposide—muscle cancer	7.16e-05	0.00159	CcSEcCtD
Dexamethasone—NR3C1—SIDS Susceptibility Pathways—TP73—muscle cancer	7.15e-05	0.00533	CbGpPWpGaD
Dexamethasone—CYP4A11—Arachidonic acid metabolism—PTGS2—muscle cancer	7.13e-05	0.00531	CbGpPWpGaD
Dexamethasone—Asthenia—Vincristine—muscle cancer	7.07e-05	0.00157	CcSEcCtD
Dexamethasone—ANXA1—Class A/1 (Rhodopsin-like receptors)—CNR1—muscle cancer	7.05e-05	0.00525	CbGpPWpGaD
Dexamethasone—Vomiting—Dactinomycin—muscle cancer	7.01e-05	0.00156	CcSEcCtD
Dexamethasone—PGR—Signaling by ERBB4—FOXO4—muscle cancer	7e-05	0.00521	CbGpPWpGaD
Dexamethasone—Rash—Dactinomycin—muscle cancer	6.95e-05	0.00155	CcSEcCtD
Dexamethasone—NR3C1—Regulation of Androgen receptor activity—FOXO1—muscle cancer	6.94e-05	0.00517	CbGpPWpGaD
Dexamethasone—Decreased appetite—Etoposide—muscle cancer	6.94e-05	0.00154	CcSEcCtD
Dexamethasone—Gastrointestinal disorder—Etoposide—muscle cancer	6.89e-05	0.00153	CcSEcCtD
Dexamethasone—Fatigue—Etoposide—muscle cancer	6.88e-05	0.00153	CcSEcCtD
Dexamethasone—Pain—Etoposide—muscle cancer	6.82e-05	0.00152	CcSEcCtD
Dexamethasone—Haemoglobin—Methotrexate—muscle cancer	6.76e-05	0.0015	CcSEcCtD
Dexamethasone—Diarrhoea—Vincristine—muscle cancer	6.74e-05	0.0015	CcSEcCtD
Dexamethasone—Haemorrhage—Methotrexate—muscle cancer	6.73e-05	0.0015	CcSEcCtD
Dexamethasone—ANXA1—Spinal Cord Injury—PTGS2—muscle cancer	6.7e-05	0.00499	CbGpPWpGaD
Dexamethasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—FOXO4—muscle cancer	6.69e-05	0.00499	CbGpPWpGaD
Dexamethasone—Weight increased—Doxorubicin—muscle cancer	6.62e-05	0.00147	CcSEcCtD
Dexamethasone—Weight decreased—Doxorubicin—muscle cancer	6.58e-05	0.00146	CcSEcCtD
Dexamethasone—Feeling abnormal—Etoposide—muscle cancer	6.57e-05	0.00146	CcSEcCtD
Dexamethasone—Hyperglycaemia—Doxorubicin—muscle cancer	6.56e-05	0.00146	CcSEcCtD
Dexamethasone—Nausea—Dactinomycin—muscle cancer	6.55e-05	0.00146	CcSEcCtD
Dexamethasone—Gastrointestinal pain—Etoposide—muscle cancer	6.52e-05	0.00145	CcSEcCtD
Dexamethasone—Dizziness—Vincristine—muscle cancer	6.51e-05	0.00145	CcSEcCtD
Dexamethasone—Visual impairment—Methotrexate—muscle cancer	6.48e-05	0.00144	CcSEcCtD
Dexamethasone—NR3C2—Generic Transcription Pathway—MED12—muscle cancer	6.4e-05	0.00477	CbGpPWpGaD
Dexamethasone—ANXA1—GPCR ligand binding—PTCH1—muscle cancer	6.36e-05	0.00474	CbGpPWpGaD
Dexamethasone—Neuropathy peripheral—Doxorubicin—muscle cancer	6.36e-05	0.00141	CcSEcCtD
Dexamethasone—Urticaria—Etoposide—muscle cancer	6.34e-05	0.00141	CcSEcCtD
Dexamethasone—NOS2—HIF-1-alpha transcription factor network—VEGFA—muscle cancer	6.33e-05	0.00472	CbGpPWpGaD
Dexamethasone—Body temperature increased—Etoposide—muscle cancer	6.31e-05	0.0014	CcSEcCtD
Dexamethasone—Abdominal pain—Etoposide—muscle cancer	6.31e-05	0.0014	CcSEcCtD
Dexamethasone—Conjunctivitis—Doxorubicin—muscle cancer	6.31e-05	0.0014	CcSEcCtD
Dexamethasone—ABCB1—bone marrow—muscle cancer	6.3e-05	0.00287	CbGeAlD
Dexamethasone—Eye disorder—Methotrexate—muscle cancer	6.29e-05	0.0014	CcSEcCtD
Dexamethasone—Vomiting—Vincristine—muscle cancer	6.26e-05	0.00139	CcSEcCtD
Dexamethasone—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—muscle cancer	6.25e-05	0.00466	CbGpPWpGaD
Dexamethasone—Rash—Vincristine—muscle cancer	6.21e-05	0.00138	CcSEcCtD
Dexamethasone—Dermatitis—Vincristine—muscle cancer	6.2e-05	0.00138	CcSEcCtD
Dexamethasone—CYP2C19—Melatonin metabolism and effects—FOXO1—muscle cancer	6.19e-05	0.00461	CbGpPWpGaD
Dexamethasone—Headache—Vincristine—muscle cancer	6.17e-05	0.00137	CcSEcCtD
Dexamethasone—Angiopathy—Methotrexate—muscle cancer	6.1e-05	0.00136	CcSEcCtD
Dexamethasone—NOS2—Hemostasis—ANGPT2—muscle cancer	6.09e-05	0.00454	CbGpPWpGaD
Dexamethasone—ABCB1—vagina—muscle cancer	6.04e-05	0.00275	CbGeAlD
Dexamethasone—Alopecia—Methotrexate—muscle cancer	5.94e-05	0.00132	CcSEcCtD
Dexamethasone—Bradycardia—Doxorubicin—muscle cancer	5.93e-05	0.00132	CcSEcCtD
Dexamethasone—PLA2G1B—Metabolism of lipids and lipoproteins—MED12—muscle cancer	5.88e-05	0.00438	CbGpPWpGaD
Dexamethasone—Erythema—Methotrexate—muscle cancer	5.86e-05	0.0013	CcSEcCtD
Dexamethasone—Haemoglobin—Doxorubicin—muscle cancer	5.85e-05	0.0013	CcSEcCtD
Dexamethasone—Nausea—Vincristine—muscle cancer	5.85e-05	0.0013	CcSEcCtD
Dexamethasone—Haemorrhage—Doxorubicin—muscle cancer	5.82e-05	0.0013	CcSEcCtD
Dexamethasone—Asthenia—Etoposide—muscle cancer	5.72e-05	0.00127	CcSEcCtD
Dexamethasone—CYP2C19—Constitutive Androstane Receptor Pathway—FOXO1—muscle cancer	5.72e-05	0.00426	CbGpPWpGaD
Dexamethasone—ANXA1—Integrated Breast Cancer Pathway—MDM2—muscle cancer	5.7e-05	0.00425	CbGpPWpGaD
Dexamethasone—CYP2D6—Melatonin metabolism and effects—FOXO1—muscle cancer	5.69e-05	0.00424	CbGpPWpGaD
Dexamethasone—Pruritus—Etoposide—muscle cancer	5.64e-05	0.00126	CcSEcCtD
Dexamethasone—Visual impairment—Doxorubicin—muscle cancer	5.61e-05	0.00125	CcSEcCtD
Dexamethasone—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—muscle cancer	5.6e-05	0.00417	CbGpPWpGaD
Dexamethasone—ABCB1—Constitutive Androstane Receptor Pathway—FOXO1—muscle cancer	5.58e-05	0.00416	CbGpPWpGaD
Dexamethasone—ABCB1—head—muscle cancer	5.58e-05	0.00254	CbGeAlD
Dexamethasone—Diarrhoea—Etoposide—muscle cancer	5.46e-05	0.00121	CcSEcCtD
Dexamethasone—PTGS2—S1P1 pathway—VEGFA—muscle cancer	5.45e-05	0.00406	CbGpPWpGaD
Dexamethasone—Eye disorder—Doxorubicin—muscle cancer	5.44e-05	0.00121	CcSEcCtD
Dexamethasone—Ill-defined disorder—Methotrexate—muscle cancer	5.43e-05	0.00121	CcSEcCtD
Dexamethasone—ABCB1—testis—muscle cancer	5.39e-05	0.00245	CbGeAlD
Dexamethasone—ANXA1—GPCR ligand binding—CNR1—muscle cancer	5.37e-05	0.004	CbGpPWpGaD
Dexamethasone—CYP19A1—Tryptophan metabolism—MDM2—muscle cancer	5.29e-05	0.00394	CbGpPWpGaD
Dexamethasone—Angiopathy—Doxorubicin—muscle cancer	5.28e-05	0.00118	CcSEcCtD
Dexamethasone—Malaise—Methotrexate—muscle cancer	5.28e-05	0.00117	CcSEcCtD
Dexamethasone—Dizziness—Etoposide—muscle cancer	5.28e-05	0.00117	CcSEcCtD
Dexamethasone—Vertigo—Methotrexate—muscle cancer	5.26e-05	0.00117	CcSEcCtD
Dexamethasone—CYP2C9—Constitutive Androstane Receptor Pathway—FOXO1—muscle cancer	5.22e-05	0.00389	CbGpPWpGaD
Dexamethasone—Arrhythmia—Doxorubicin—muscle cancer	5.2e-05	0.00116	CcSEcCtD
Dexamethasone—PGR—Signaling by ERBB4—FOXO1—muscle cancer	5.17e-05	0.00385	CbGpPWpGaD
Dexamethasone—Alopecia—Doxorubicin—muscle cancer	5.15e-05	0.00114	CcSEcCtD
Dexamethasone—NR3C1—Adipogenesis—HMGA1—muscle cancer	5.11e-05	0.00381	CbGpPWpGaD
Dexamethasone—CYP1B1—Tryptophan metabolism—MDM2—muscle cancer	5.1e-05	0.0038	CbGpPWpGaD
Dexamethasone—Convulsion—Methotrexate—muscle cancer	5.07e-05	0.00113	CcSEcCtD
Dexamethasone—Vomiting—Etoposide—muscle cancer	5.07e-05	0.00113	CcSEcCtD
Dexamethasone—Erythema—Doxorubicin—muscle cancer	5.07e-05	0.00113	CcSEcCtD
Dexamethasone—NOS2—Spinal Cord Injury—PTGS2—muscle cancer	5.05e-05	0.00376	CbGpPWpGaD
Dexamethasone—Rash—Etoposide—muscle cancer	5.03e-05	0.00112	CcSEcCtD
Dexamethasone—Dermatitis—Etoposide—muscle cancer	5.03e-05	0.00112	CcSEcCtD
Dexamethasone—Headache—Etoposide—muscle cancer	5e-05	0.00111	CcSEcCtD
Dexamethasone—Myalgia—Methotrexate—muscle cancer	4.99e-05	0.00111	CcSEcCtD
Dexamethasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—FOXO1—muscle cancer	4.94e-05	0.00368	CbGpPWpGaD
Dexamethasone—Discomfort—Methotrexate—muscle cancer	4.93e-05	0.0011	CcSEcCtD
Dexamethasone—CYP1B1—Aryl Hydrocarbon Receptor—PTGS2—muscle cancer	4.91e-05	0.00366	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—KIDINS220—muscle cancer	4.9e-05	0.00365	CbGpPWpGaD
Dexamethasone—Anaphylactic shock—Methotrexate—muscle cancer	4.78e-05	0.00106	CcSEcCtD
Dexamethasone—Infection—Methotrexate—muscle cancer	4.75e-05	0.00106	CcSEcCtD
Dexamethasone—CYP1A1—PPARA activates gene expression—MED12—muscle cancer	4.74e-05	0.00353	CbGpPWpGaD
Dexamethasone—Nausea—Etoposide—muscle cancer	4.74e-05	0.00105	CcSEcCtD
Dexamethasone—NOS2—Rac1/Pak1/p38/MMP-2 pathway—TP53—muscle cancer	4.73e-05	0.00352	CbGpPWpGaD
Dexamethasone—ANXA1—Integrated Pancreatic Cancer Pathway—MDM2—muscle cancer	4.73e-05	0.00352	CbGpPWpGaD
Dexamethasone—Ill-defined disorder—Doxorubicin—muscle cancer	4.7e-05	0.00105	CcSEcCtD
Dexamethasone—Nervous system disorder—Methotrexate—muscle cancer	4.69e-05	0.00104	CcSEcCtD
Dexamethasone—Thrombocytopenia—Methotrexate—muscle cancer	4.68e-05	0.00104	CcSEcCtD
Dexamethasone—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—MED12—muscle cancer	4.64e-05	0.00346	CbGpPWpGaD
Dexamethasone—PLA2G1B—Metabolism—FH—muscle cancer	4.64e-05	0.00345	CbGpPWpGaD
Dexamethasone—Hyperhidrosis—Methotrexate—muscle cancer	4.62e-05	0.00103	CcSEcCtD
Dexamethasone—CYP1B1—Arachidonic acid metabolism—PTGS2—muscle cancer	4.59e-05	0.00342	CbGpPWpGaD
Dexamethasone—Malaise—Doxorubicin—muscle cancer	4.57e-05	0.00102	CcSEcCtD
Dexamethasone—ANXA1—Integrated Pancreatic Cancer Pathway—PTGS2—muscle cancer	4.56e-05	0.00339	CbGpPWpGaD
Dexamethasone—Vertigo—Doxorubicin—muscle cancer	4.56e-05	0.00101	CcSEcCtD
Dexamethasone—Anorexia—Methotrexate—muscle cancer	4.56e-05	0.00101	CcSEcCtD
Dexamethasone—Syncope—Doxorubicin—muscle cancer	4.55e-05	0.00101	CcSEcCtD
Dexamethasone—ABCG2—HIF-2-alpha transcription factor network—VEGFA—muscle cancer	4.48e-05	0.00334	CbGpPWpGaD
Dexamethasone—Hypotension—Methotrexate—muscle cancer	4.47e-05	0.000993	CcSEcCtD
Dexamethasone—Loss of consciousness—Doxorubicin—muscle cancer	4.46e-05	0.000991	CcSEcCtD
Dexamethasone—Convulsion—Doxorubicin—muscle cancer	4.39e-05	0.000977	CcSEcCtD
Dexamethasone—Hypertension—Doxorubicin—muscle cancer	4.38e-05	0.000974	CcSEcCtD
Dexamethasone—Musculoskeletal discomfort—Methotrexate—muscle cancer	4.35e-05	0.000968	CcSEcCtD
Dexamethasone—ANXA1—Integrated Breast Cancer Pathway—VEGFA—muscle cancer	4.33e-05	0.00323	CbGpPWpGaD
Dexamethasone—Insomnia—Methotrexate—muscle cancer	4.32e-05	0.000961	CcSEcCtD
Dexamethasone—Myalgia—Doxorubicin—muscle cancer	4.32e-05	0.00096	CcSEcCtD
Dexamethasone—Anxiety—Doxorubicin—muscle cancer	4.3e-05	0.000957	CcSEcCtD
Dexamethasone—Paraesthesia—Methotrexate—muscle cancer	4.29e-05	0.000955	CcSEcCtD
Dexamethasone—Discomfort—Doxorubicin—muscle cancer	4.26e-05	0.000949	CcSEcCtD
Dexamethasone—Dyspepsia—Methotrexate—muscle cancer	4.21e-05	0.000936	CcSEcCtD
Dexamethasone—NR3C1—Regulation of Androgen receptor activity—MDM2—muscle cancer	4.17e-05	0.0031	CbGpPWpGaD
Dexamethasone—Decreased appetite—Methotrexate—muscle cancer	4.15e-05	0.000924	CcSEcCtD
Dexamethasone—Oedema—Doxorubicin—muscle cancer	4.14e-05	0.00092	CcSEcCtD
Dexamethasone—Anaphylactic shock—Doxorubicin—muscle cancer	4.14e-05	0.00092	CcSEcCtD
Dexamethasone—Gastrointestinal disorder—Methotrexate—muscle cancer	4.13e-05	0.000918	CcSEcCtD
Dexamethasone—Fatigue—Methotrexate—muscle cancer	4.12e-05	0.000916	CcSEcCtD
Dexamethasone—Infection—Doxorubicin—muscle cancer	4.11e-05	0.000914	CcSEcCtD
Dexamethasone—Pain—Methotrexate—muscle cancer	4.09e-05	0.000909	CcSEcCtD
Dexamethasone—Shock—Doxorubicin—muscle cancer	4.07e-05	0.000906	CcSEcCtD
Dexamethasone—Nervous system disorder—Doxorubicin—muscle cancer	4.06e-05	0.000903	CcSEcCtD
Dexamethasone—Thrombocytopenia—Doxorubicin—muscle cancer	4.05e-05	0.000901	CcSEcCtD
Dexamethasone—Tachycardia—Doxorubicin—muscle cancer	4.04e-05	0.000898	CcSEcCtD
Dexamethasone—NR0B1—Gene Expression—MED12—muscle cancer	4.04e-05	0.00301	CbGpPWpGaD
Dexamethasone—Hyperhidrosis—Doxorubicin—muscle cancer	4e-05	0.00089	CcSEcCtD
Dexamethasone—ANXA1—Spinal Cord Injury—TP53—muscle cancer	3.99e-05	0.00297	CbGpPWpGaD
Dexamethasone—Anorexia—Doxorubicin—muscle cancer	3.94e-05	0.000877	CcSEcCtD
Dexamethasone—PGR—Signaling by ERBB4—KIT—muscle cancer	3.94e-05	0.00293	CbGpPWpGaD
Dexamethasone—Feeling abnormal—Methotrexate—muscle cancer	3.94e-05	0.000876	CcSEcCtD
Dexamethasone—Gastrointestinal pain—Methotrexate—muscle cancer	3.91e-05	0.000869	CcSEcCtD
Dexamethasone—PGR—Generic Transcription Pathway—MED12—muscle cancer	3.9e-05	0.0029	CbGpPWpGaD
Dexamethasone—CYP1B1—Aryl Hydrocarbon Receptor—VEGFA—muscle cancer	3.87e-05	0.00288	CbGpPWpGaD
Dexamethasone—Hypotension—Doxorubicin—muscle cancer	3.87e-05	0.00086	CcSEcCtD
Dexamethasone—Urticaria—Methotrexate—muscle cancer	3.8e-05	0.000844	CcSEcCtD
Dexamethasone—Abdominal pain—Methotrexate—muscle cancer	3.78e-05	0.00084	CcSEcCtD
Dexamethasone—Body temperature increased—Methotrexate—muscle cancer	3.78e-05	0.00084	CcSEcCtD
Dexamethasone—Musculoskeletal discomfort—Doxorubicin—muscle cancer	3.77e-05	0.000839	CcSEcCtD
Dexamethasone—Insomnia—Doxorubicin—muscle cancer	3.74e-05	0.000833	CcSEcCtD
Dexamethasone—Paraesthesia—Doxorubicin—muscle cancer	3.72e-05	0.000827	CcSEcCtD
Dexamethasone—CYP3A43—Metabolism—FH—muscle cancer	3.65e-05	0.00272	CbGpPWpGaD
Dexamethasone—Dyspepsia—Doxorubicin—muscle cancer	3.64e-05	0.00081	CcSEcCtD
Dexamethasone—Decreased appetite—Doxorubicin—muscle cancer	3.6e-05	0.0008	CcSEcCtD
Dexamethasone—ANXA1—Integrated Pancreatic Cancer Pathway—VEGFA—muscle cancer	3.59e-05	0.00267	CbGpPWpGaD
Dexamethasone—Gastrointestinal disorder—Doxorubicin—muscle cancer	3.57e-05	0.000795	CcSEcCtD
Dexamethasone—Fatigue—Doxorubicin—muscle cancer	3.57e-05	0.000794	CcSEcCtD
Dexamethasone—CYP17A1—Metabolism of lipids and lipoproteins—MED12—muscle cancer	3.54e-05	0.00264	CbGpPWpGaD
Dexamethasone—Pain—Doxorubicin—muscle cancer	3.54e-05	0.000787	CcSEcCtD
Dexamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—WT1—muscle cancer	3.49e-05	0.0026	CbGpPWpGaD
Dexamethasone—ABCG2—Fluoropyrimidine Activity—TP53—muscle cancer	3.47e-05	0.00258	CbGpPWpGaD
Dexamethasone—CYP3A4—Constitutive Androstane Receptor Pathway—FOXO1—muscle cancer	3.44e-05	0.00256	CbGpPWpGaD
Dexamethasone—NR3C1—AP-1 transcription factor network—CDKN2A—muscle cancer	3.44e-05	0.00256	CbGpPWpGaD
Dexamethasone—Asthenia—Methotrexate—muscle cancer	3.43e-05	0.000763	CcSEcCtD
Dexamethasone—Feeling abnormal—Doxorubicin—muscle cancer	3.41e-05	0.000759	CcSEcCtD
Dexamethasone—CYP19A1—Integrated Breast Cancer Pathway—FOXO1—muscle cancer	3.41e-05	0.00254	CbGpPWpGaD
Dexamethasone—NR3C1—Adipogenesis—FOXO1—muscle cancer	3.39e-05	0.00252	CbGpPWpGaD
Dexamethasone—Gastrointestinal pain—Doxorubicin—muscle cancer	3.38e-05	0.000753	CcSEcCtD
Dexamethasone—Pruritus—Methotrexate—muscle cancer	3.38e-05	0.000752	CcSEcCtD
Dexamethasone—CYP2E1—Tryptophan metabolism—MDM2—muscle cancer	3.33e-05	0.00248	CbGpPWpGaD
Dexamethasone—Urticaria—Doxorubicin—muscle cancer	3.29e-05	0.000731	CcSEcCtD
Dexamethasone—ANXA1—Integrated Breast Cancer Pathway—TP53—muscle cancer	3.27e-05	0.00244	CbGpPWpGaD
Dexamethasone—Abdominal pain—Doxorubicin—muscle cancer	3.27e-05	0.000728	CcSEcCtD
Dexamethasone—Body temperature increased—Doxorubicin—muscle cancer	3.27e-05	0.000728	CcSEcCtD
Dexamethasone—Diarrhoea—Methotrexate—muscle cancer	3.27e-05	0.000727	CcSEcCtD
Dexamethasone—ANXA1—Signaling by GPCR—PTCH1—muscle cancer	3.26e-05	0.00243	CbGpPWpGaD
Dexamethasone—CYP11A1—Metabolism of lipids and lipoproteins—MED12—muscle cancer	3.24e-05	0.00242	CbGpPWpGaD
Dexamethasone—CYP4A11—Metabolism of lipids and lipoproteins—MED12—muscle cancer	3.21e-05	0.00239	CbGpPWpGaD
Dexamethasone—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—MED12—muscle cancer	3.2e-05	0.00238	CbGpPWpGaD
Dexamethasone—Dizziness—Methotrexate—muscle cancer	3.16e-05	0.000703	CcSEcCtD
Dexamethasone—CYP2A6—Fluoropyrimidine Activity—TP53—muscle cancer	3.15e-05	0.00235	CbGpPWpGaD
Dexamethasone—CYP1A1—Tryptophan metabolism—MDM2—muscle cancer	3.14e-05	0.00234	CbGpPWpGaD
Dexamethasone—PGR—Signaling by ERBB4—MDM2—muscle cancer	3.1e-05	0.00231	CbGpPWpGaD
Dexamethasone—NR3C2—Gene Expression—MED12—muscle cancer	3.08e-05	0.0023	CbGpPWpGaD
Dexamethasone—Vomiting—Methotrexate—muscle cancer	3.04e-05	0.000676	CcSEcCtD
Dexamethasone—ANXA1—GPCR downstream signaling—CNR1—muscle cancer	3.03e-05	0.00226	CbGpPWpGaD
Dexamethasone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—muscle cancer	3.03e-05	0.00225	CbGpPWpGaD
Dexamethasone—CYP1A1—Aryl Hydrocarbon Receptor—PTGS2—muscle cancer	3.02e-05	0.00225	CbGpPWpGaD
Dexamethasone—Rash—Methotrexate—muscle cancer	3.01e-05	0.00067	CcSEcCtD
Dexamethasone—Dermatitis—Methotrexate—muscle cancer	3.01e-05	0.00067	CcSEcCtD
Dexamethasone—NOS2—Spinal Cord Injury—TP53—muscle cancer	3.01e-05	0.00224	CbGpPWpGaD
Dexamethasone—Headache—Methotrexate—muscle cancer	2.99e-05	0.000666	CcSEcCtD
Dexamethasone—Asthenia—Doxorubicin—muscle cancer	2.97e-05	0.00066	CcSEcCtD
Dexamethasone—NOS2—Hemostasis—IGF2—muscle cancer	2.96e-05	0.00221	CbGpPWpGaD
Dexamethasone—NR3C1—Glucocorticoid receptor regulatory network—MDM2—muscle cancer	2.94e-05	0.00219	CbGpPWpGaD
Dexamethasone—Pruritus—Doxorubicin—muscle cancer	2.93e-05	0.000651	CcSEcCtD
Dexamethasone—ABCB11—Metabolism of lipids and lipoproteins—MED12—muscle cancer	2.85e-05	0.00212	CbGpPWpGaD
Dexamethasone—Nausea—Methotrexate—muscle cancer	2.84e-05	0.000631	CcSEcCtD
Dexamethasone—Diarrhoea—Doxorubicin—muscle cancer	2.83e-05	0.00063	CcSEcCtD
Dexamethasone—CYP1A1—Arachidonic acid metabolism—PTGS2—muscle cancer	2.83e-05	0.00211	CbGpPWpGaD
Dexamethasone—CYP17A1—Metabolism—FH—muscle cancer	2.79e-05	0.00208	CbGpPWpGaD
Dexamethasone—PTGS2—C-MYB transcription factor network—KIT—muscle cancer	2.77e-05	0.00207	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling by GPCR—CNR1—muscle cancer	2.76e-05	0.00205	CbGpPWpGaD
Dexamethasone—Dizziness—Doxorubicin—muscle cancer	2.74e-05	0.000609	CcSEcCtD
Dexamethasone—ANXA1—Integrated Pancreatic Cancer Pathway—TP53—muscle cancer	2.71e-05	0.00202	CbGpPWpGaD
Dexamethasone—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—muscle cancer	2.68e-05	0.002	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—KIDINS220—muscle cancer	2.68e-05	0.002	CbGpPWpGaD
Dexamethasone—ABCG2—HIF-1-alpha transcription factor network—VEGFA—muscle cancer	2.64e-05	0.00196	CbGpPWpGaD
Dexamethasone—Vomiting—Doxorubicin—muscle cancer	2.63e-05	0.000585	CcSEcCtD
Dexamethasone—PLA2G1B—Metabolism—MED12—muscle cancer	2.62e-05	0.00195	CbGpPWpGaD
Dexamethasone—Rash—Doxorubicin—muscle cancer	2.61e-05	0.00058	CcSEcCtD
Dexamethasone—Dermatitis—Doxorubicin—muscle cancer	2.61e-05	0.00058	CcSEcCtD
Dexamethasone—CYP2C8—Arachidonic acid metabolism—PTGS2—muscle cancer	2.59e-05	0.00193	CbGpPWpGaD
Dexamethasone—Headache—Doxorubicin—muscle cancer	2.59e-05	0.000577	CcSEcCtD
Dexamethasone—CYP11A1—Metabolism—FH—muscle cancer	2.56e-05	0.0019	CbGpPWpGaD
Dexamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—BUB1B—muscle cancer	2.55e-05	0.0019	CbGpPWpGaD
Dexamethasone—CYP4A11—Metabolism—FH—muscle cancer	2.53e-05	0.00188	CbGpPWpGaD
Dexamethasone—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—muscle cancer	2.52e-05	0.00188	CbGpPWpGaD
Dexamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—muscle cancer	2.48e-05	0.00184	CbGpPWpGaD
Dexamethasone—Nausea—Doxorubicin—muscle cancer	2.46e-05	0.000547	CcSEcCtD
Dexamethasone—PLA2G1B—Metabolism—ENO2—muscle cancer	2.39e-05	0.00178	CbGpPWpGaD
Dexamethasone—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—muscle cancer	2.38e-05	0.00178	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism of lipids and lipoproteins—MED12—muscle cancer	2.38e-05	0.00177	CbGpPWpGaD
Dexamethasone—CYP2C19—Arachidonic acid metabolism—PTGS2—muscle cancer	2.32e-05	0.00173	CbGpPWpGaD
Dexamethasone—NR3C1—Generic Transcription Pathway—MED12—muscle cancer	2.25e-05	0.00168	CbGpPWpGaD
Dexamethasone—PTGS2—C-MYB transcription factor network—CDKN2A—muscle cancer	2.25e-05	0.00168	CbGpPWpGaD
Dexamethasone—ABCB11—Metabolism—FH—muscle cancer	2.24e-05	0.00167	CbGpPWpGaD
Dexamethasone—NOS2—Disease—ENO2—muscle cancer	2.19e-05	0.00163	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism of lipids and lipoproteins—MED12—muscle cancer	2.15e-05	0.0016	CbGpPWpGaD
Dexamethasone—CYP2C9—Arachidonic acid metabolism—PTGS2—muscle cancer	2.11e-05	0.00157	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism of lipids and lipoproteins—MED12—muscle cancer	2.07e-05	0.00154	CbGpPWpGaD
Dexamethasone—CYP3A43—Metabolism—MED12—muscle cancer	2.06e-05	0.00154	CbGpPWpGaD
Dexamethasone—CYP19A1—Integrated Breast Cancer Pathway—MDM2—muscle cancer	2.04e-05	0.00152	CbGpPWpGaD
Dexamethasone—NOS2—Disease—HMGA1—muscle cancer	1.99e-05	0.00148	CbGpPWpGaD
Dexamethasone—NOS2—Circadian rythm related genes—TP53—muscle cancer	1.96e-05	0.00146	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—PTCH1—muscle cancer	1.93e-05	0.00144	CbGpPWpGaD
Dexamethasone—NR3C1—AP-1 transcription factor network—TP53—muscle cancer	1.91e-05	0.00143	CbGpPWpGaD
Dexamethasone—CYP3A43—Metabolism—ENO2—muscle cancer	1.88e-05	0.0014	CbGpPWpGaD
Dexamethasone—PGR—Gene Expression—MED12—muscle cancer	1.88e-05	0.0014	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism—FH—muscle cancer	1.87e-05	0.0014	CbGpPWpGaD
Dexamethasone—PLA2G1B—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	1.87e-05	0.00139	CbGpPWpGaD
Dexamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—BUB1B—muscle cancer	1.81e-05	0.00135	CbGpPWpGaD
Dexamethasone—NOS2—Disease—FOXO4—muscle cancer	1.79e-05	0.00133	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—FH—muscle cancer	1.69e-05	0.00126	CbGpPWpGaD
Dexamethasone—NR3C1—Glucocorticoid receptor regulatory network—TP53—muscle cancer	1.69e-05	0.00126	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—FOXO4—muscle cancer	1.66e-05	0.00124	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—FH—muscle cancer	1.63e-05	0.00121	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—CNR1—muscle cancer	1.63e-05	0.00121	CbGpPWpGaD
Dexamethasone—CYP17A1—Metabolism—MED12—muscle cancer	1.58e-05	0.00118	CbGpPWpGaD
Dexamethasone—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—muscle cancer	1.55e-05	0.00116	CbGpPWpGaD
Dexamethasone—CYP3A4—Tryptophan metabolism—MDM2—muscle cancer	1.54e-05	0.00115	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—FH—muscle cancer	1.48e-05	0.0011	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—FH—muscle cancer	1.47e-05	0.0011	CbGpPWpGaD
Dexamethasone—CYP11A1—Metabolism—MED12—muscle cancer	1.44e-05	0.00108	CbGpPWpGaD
Dexamethasone—CYP17A1—Metabolism—ENO2—muscle cancer	1.44e-05	0.00107	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism of lipids and lipoproteins—MED12—muscle cancer	1.44e-05	0.00107	CbGpPWpGaD
Dexamethasone—CYP4A11—Metabolism—MED12—muscle cancer	1.43e-05	0.00106	CbGpPWpGaD
Dexamethasone—ABCB1—HIF-1-alpha transcription factor network—VEGFA—muscle cancer	1.43e-05	0.00106	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—FH—muscle cancer	1.35e-05	0.001	CbGpPWpGaD
Dexamethasone—NR3C1—SIDS Susceptibility Pathways—VEGFA—muscle cancer	1.33e-05	0.000994	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—IGF2—muscle cancer	1.33e-05	0.000991	CbGpPWpGaD
Dexamethasone—NOS2—Disease—FOXO1—muscle cancer	1.32e-05	0.000983	CbGpPWpGaD
Dexamethasone—CYP11A1—Metabolism—ENO2—muscle cancer	1.32e-05	0.000981	CbGpPWpGaD
Dexamethasone—CYP4A11—Metabolism—ENO2—muscle cancer	1.3e-05	0.000971	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism of lipids and lipoproteins—MED12—muscle cancer	1.27e-05	0.000949	CbGpPWpGaD
Dexamethasone—ABCB11—Metabolism—MED12—muscle cancer	1.27e-05	0.000944	CbGpPWpGaD
Dexamethasone—NOS2—Hemostasis—VEGFA—muscle cancer	1.24e-05	0.000925	CbGpPWpGaD
Dexamethasone—ABCB1—Allograft Rejection—VEGFA—muscle cancer	1.23e-05	0.00092	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—FOXO1—muscle cancer	1.22e-05	0.000912	CbGpPWpGaD
Dexamethasone—CYP19A1—Integrated Breast Cancer Pathway—TP53—muscle cancer	1.17e-05	0.000874	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism of lipids and lipoproteins—MED12—muscle cancer	1.17e-05	0.00087	CbGpPWpGaD
Dexamethasone—ABCB11—Metabolism—ENO2—muscle cancer	1.16e-05	0.000861	CbGpPWpGaD
Dexamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—MDM2—muscle cancer	1.13e-05	0.000843	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—FH—muscle cancer	1.13e-05	0.000843	CbGpPWpGaD
Dexamethasone—CYP17A1—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	1.13e-05	0.000839	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—FH—muscle cancer	1.09e-05	0.00081	CbGpPWpGaD
Dexamethasone—NR3C1—Gene Expression—MED12—muscle cancer	1.08e-05	0.000808	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—FH—muscle cancer	1.06e-05	0.000793	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—FH—muscle cancer	1.06e-05	0.000792	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism—MED12—muscle cancer	1.06e-05	0.000788	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—PTCH1—muscle cancer	1.05e-05	0.000786	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism of lipids and lipoproteins—MED12—muscle cancer	1.04e-05	0.000776	CbGpPWpGaD
Dexamethasone—CYP11A1—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	1.03e-05	0.000767	CbGpPWpGaD
Dexamethasone—CYP4A11—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	1.02e-05	0.000759	CbGpPWpGaD
Dexamethasone—NOS2—Disease—KIT—muscle cancer	1.01e-05	0.000749	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—FH—muscle cancer	1e-05	0.000748	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism—ENO2—muscle cancer	9.65e-06	0.000719	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—MED12—muscle cancer	9.56e-06	0.000713	CbGpPWpGaD
Dexamethasone—PTGS2—Spinal Cord Injury—TP53—muscle cancer	9.55e-06	0.000711	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism of lipids and lipoproteins—MED12—muscle cancer	9.5e-06	0.000708	CbGpPWpGaD
Dexamethasone—NOS2—Hemostasis—TP53—muscle cancer	9.38e-06	0.000699	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—KIT—muscle cancer	9.33e-06	0.000695	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—MED12—muscle cancer	9.21e-06	0.000686	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—FH—muscle cancer	9.2e-06	0.000686	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—FOXO4—muscle cancer	9.07e-06	0.000675	CbGpPWpGaD
Dexamethasone—ABCB11—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	9.04e-06	0.000673	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—CNR1—muscle cancer	8.9e-06	0.000663	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—ENO2—muscle cancer	8.72e-06	0.00065	CbGpPWpGaD
Dexamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—muscle cancer	8.6e-06	0.00064	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—ENO2—muscle cancer	8.4e-06	0.000626	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—MED12—muscle cancer	8.38e-06	0.000624	CbGpPWpGaD
Dexamethasone—PLA2G1B—Metabolism—PTGS2—muscle cancer	8.32e-06	0.00062	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—MED12—muscle cancer	8.31e-06	0.000619	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—FH—muscle cancer	8.21e-06	0.000612	CbGpPWpGaD
Dexamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—muscle cancer	8.02e-06	0.000598	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—FH—muscle cancer	8.02e-06	0.000597	CbGpPWpGaD
Dexamethasone—NOS2—Disease—MDM2—muscle cancer	7.92e-06	0.00059	CbGpPWpGaD
Dexamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—muscle cancer	7.74e-06	0.000576	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—ENO2—muscle cancer	7.64e-06	0.000569	CbGpPWpGaD
Dexamethasone—NOS2—Disease—PTGS2—muscle cancer	7.63e-06	0.000569	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—MED12—muscle cancer	7.61e-06	0.000567	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—ENO2—muscle cancer	7.57e-06	0.000564	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—FH—muscle cancer	7.56e-06	0.000563	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	7.55e-06	0.000562	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—FH—muscle cancer	7.49e-06	0.000558	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—MDM2—muscle cancer	7.35e-06	0.000548	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—IGF2—muscle cancer	7.28e-06	0.000542	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—ENO2—muscle cancer	6.96e-06	0.000518	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—ENO2—muscle cancer	6.94e-06	0.000517	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	6.82e-06	0.000508	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—FOXO1—muscle cancer	6.7e-06	0.000499	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	6.57e-06	0.000489	CbGpPWpGaD
Dexamethasone—CYP3A43—Metabolism—PTGS2—muscle cancer	6.55e-06	0.000488	CbGpPWpGaD
Dexamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—muscle cancer	6.49e-06	0.000484	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—MED12—muscle cancer	6.39e-06	0.000476	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—HMGA1—muscle cancer	6.32e-06	0.000471	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—MED12—muscle cancer	6.14e-06	0.000458	CbGpPWpGaD
Dexamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—muscle cancer	6.09e-06	0.000454	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—MED12—muscle cancer	6.02e-06	0.000448	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—MED12—muscle cancer	6e-06	0.000447	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—ENO2—muscle cancer	5.83e-06	0.000434	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—MED12—muscle cancer	5.67e-06	0.000423	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—FOXO4—muscle cancer	5.67e-06	0.000423	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—ENO2—muscle cancer	5.6e-06	0.000417	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—VEGFA—muscle cancer	5.58e-06	0.000416	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—ENO2—muscle cancer	5.48e-06	0.000409	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—ENO2—muscle cancer	5.47e-06	0.000408	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—MED12—muscle cancer	5.2e-06	0.000387	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—ENO2—muscle cancer	5.17e-06	0.000385	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—KIT—muscle cancer	5.1e-06	0.00038	CbGpPWpGaD
Dexamethasone—CYP17A1—Metabolism—PTGS2—muscle cancer	5.01e-06	0.000373	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—FH—muscle cancer	4.94e-06	0.000368	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—ENO2—muscle cancer	4.74e-06	0.000353	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—MED12—muscle cancer	4.64e-06	0.000346	CbGpPWpGaD
Dexamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—muscle cancer	4.6e-06	0.000343	CbGpPWpGaD
Dexamethasone—CYP11A1—Metabolism—PTGS2—muscle cancer	4.58e-06	0.000342	CbGpPWpGaD
Dexamethasone—CYP4A11—Metabolism—PTGS2—muscle cancer	4.54e-06	0.000338	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—MED12—muscle cancer	4.53e-06	0.000338	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—MED12—muscle cancer	4.27e-06	0.000318	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—MED12—muscle cancer	4.23e-06	0.000315	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—ENO2—muscle cancer	4.23e-06	0.000315	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—TP53—muscle cancer	4.22e-06	0.000314	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—FOXO1—muscle cancer	4.19e-06	0.000312	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—ENO2—muscle cancer	4.13e-06	0.000308	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	4.04e-06	0.000301	CbGpPWpGaD
Dexamethasone—ABCB11—Metabolism—PTGS2—muscle cancer	4.03e-06	0.0003	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—MDM2—muscle cancer	4.02e-06	0.000299	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—ENO2—muscle cancer	3.89e-06	0.00029	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—ENO2—muscle cancer	3.86e-06	0.000287	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	3.71e-06	0.000276	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism—PTGS2—muscle cancer	3.36e-06	0.00025	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	3.31e-06	0.000247	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—KIT—muscle cancer	3.19e-06	0.000238	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—VEGFA—muscle cancer	3.05e-06	0.000227	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—PTGS2—muscle cancer	3.04e-06	0.000226	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	3.02e-06	0.000225	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—PTGS2—muscle cancer	2.92e-06	0.000218	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—MED12—muscle cancer	2.79e-06	0.000208	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—PTGS2—muscle cancer	2.66e-06	0.000198	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—PTGS2—muscle cancer	2.64e-06	0.000196	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—ENO2—muscle cancer	2.54e-06	0.00019	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—MDM2—muscle cancer	2.51e-06	0.000187	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—PTGS2—muscle cancer	2.42e-06	0.00018	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—TP53—muscle cancer	2.31e-06	0.000172	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—PTGS2—muscle cancer	1.95e-06	0.000145	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—PTGS2—muscle cancer	1.91e-06	0.000142	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—PTGS2—muscle cancer	1.91e-06	0.000142	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—PTGS2—muscle cancer	1.8e-06	0.000134	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—PTGS2—muscle cancer	1.65e-06	0.000123	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—PTGS2—muscle cancer	1.47e-06	0.00011	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—PTGS2—muscle cancer	1.44e-06	0.000107	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—PTGS2—muscle cancer	1.36e-06	0.000101	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—PTGS2—muscle cancer	1.34e-06	0.0001	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—PTGS2—muscle cancer	8.86e-07	6.6e-05	CbGpPWpGaD
